Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CDX-110

Known as: CDX 110, CDX110 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND The epidermal growth factor receptor variant III deletion mutation, EGFRvIII, is expressed in ∼30% of primary… Expand
Is this relevant?
Highly Cited
2015
Highly Cited
2015
2009 Background: EGFRvIII, a constitutively active EGFR deletion driver mutation, is associated with poor long-term survival in… Expand
Is this relevant?
2015
2015
Author(s): Reardon, DA; Schuster, JM; Tran, DD; Fink, KL; Nabors, LB; Li, G; Bota, DA; Lukas, RV; Desjardins, A; Ashby, LS; Duic… Expand
Is this relevant?
2015
2015
G lioblastoma multiforme (GBM) is the most common primary brain tumor in adults. Standard therapy, including maximal surgical… Expand
Is this relevant?
2014
2014
BACKGROUND: EGFRvIII, a constitutively active tumorigenic EGFR deletion mutation, is linked to poor long-term survival. The… Expand
Is this relevant?
2012
2012
TPS2103 Background: EGFRvIII is a constitutively active tumorigenic deletion mutation of EGFR. It is expressed in ~30% of primary… Expand
Is this relevant?
2011
2011
  • M. Chamberlain
  • Journal of clinical oncology : official journal…
  • 2011
  • Corpus ID: 207028713
TO THE EDITOR: Sampson et al are to be congratulated for their paper on the use of the epidermal growth factor receptor variant… Expand
Is this relevant?
2010
2010
2014 Background: EGFRvIII is a constitutively activated mutation of EGFR, not expressed in normal tissues but expressed in GBM… Expand
Is this relevant?
2009
2009
2021 Background: Unlike conventional therapies for GBM, immunologic targeting of tumor-specific gene mutations allows precise… Expand
Is this relevant?
2008
2008
2011 Background: Conventional therapies for GBM fail to target tumor cells exclusively. Immunologic targeting of tumor- specific… Expand
Is this relevant?